GlassScriptPhysician profile
Matthew L Edwards
NPI 1073877098
$14,398.22
in general payments reported to CMS, 2019-2025
46 companies · $844 in 2025
The $844 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,996 · 2020: $876 · 2021: $1,458 · 2022: $4,630 · 2023: $1,627 · 2024: $1,966 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,437.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,147.09 | 2022 | |
| Abbott Laboratories | $2,053.31 | 2019-2025 | Aveir, Cardiomems, Pressurewire |
| Boston Scientific Corporation | $1,548.73 | 2019-2025 | Eluvia, Watchman Flx, Ekosonic |
| Novartis Pharmaceuticals Corporation | $904.23 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $694.39 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $647.85 | 2022-2025 | Assure Wcd |
| Inari Medical, INC. | $638.74 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $458.74 | 2019-2024 | Xarelto |
| Amgen INC. | $414.09 | 2019-2025 | Repatha, Repatha |
| Abiomed | $410.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $327.33 | 2019-2024 | Farxiga, Brilinta |
| Angiodynamics, INC. | $301.78 | 2023-2024 | Auryon Laser System 100-120 Vac, Alphavac |
| Pfizer INC. | $252.69 | 2019-2025 | |
| Philips North America LLC | $235.02 | 2019-2021 | |
| Terumo Medical Corporation | $228.85 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $198.76 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.48 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $169.03 | 2021-2022 | |
| Medtronic USA, INC. | $168.03 | 2019-2020 | |
| Cardiovascular Systems INC. | $149.55 | 2020 | |
| Medtronic Vascular, INC. | $126.48 | 2019 | |
| Bracco Diagnostics INC. | $124.96 | 2019 | |
| Zoll Circulation INC | $120.00 | 2022 | |
| Medtronic, INC. | $113.28 | 2021-2025 | Venaseal, Closurefast |
| Novo Nordisk INC | $89.72 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $76.75 | 2022-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $67.15 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $66.70 | 2024 | Arcalyst |
| Shockwave Medical, INC | $63.20 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $47.95 | 2023-2025 | |
| Esperion Therapeutics, INC. | $43.96 | 2021-2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $43.65 | 2023 | Arcalyst |
| Heartflow, INC. | $43.59 | 2023-2025 | Ffrct |
| Actelion Pharmaceuticals US, INC. | $28.88 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.85 | 2022 | |
| Daiichi Sankyo INC. | $21.81 | 2023 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $21.62 | 2023 | Livalo |
| Bard Peripheral Vascular, INC. | $16.41 | 2024 | Venclose Maven Catheter |
| Surmodics, INC. | $16.34 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Cardinal Health 200 LLC | $16.33 | 2019 | |
| Cmp Pharma, INC. | $15.77 | 2022 | |
| Baxter Healthcare | $15.22 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bardy Diagnostics, INC. | $14.40 | 2022 | |
| Edwards Lifesciences Corporation | $14.26 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $13.60 | 2025 | Rhythm Express |
| Teleflex LLC | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.